PhRMA To Announce Clinical Trial Registry Sept. 8
This article was originally published in The Pink Sheet Daily
The Pharmaceutical Research & Manufacturers of America is expected to announce an industry-wide clinical trial registry plan Sept. 8
You may also be interested in...
House Commerce/Oversight Subcommittee Vice Chairman Greg Walden will oversee discussion of FDA, industry handling of data on antidepressant-related pediatric suicides.
Company posts 64 study summaries for the diabetes drug on its new clinical trial registry. Avandia summaries offer first real-world example of how industry trial registries will work.
A Senate Health Committee update hearing on the COVID-19 federal response was noteworthy primarily for demonstrating that FDA Commissioner Stephen Hahn appears to have salvaged the agency’s position as a voice of credibility with a key political constituency – at least for now.